Generics Access Project, patient advocacy orgs urge Congressional action to alleviate drug shortage crisisThe organizations sent a letter on May 21 to the Senate HELP and House Energy & Commerce leadership to stress congressional action to alleviate the worsening drug shortage crisis. Alvotech, Dr. Reddy’s collaborate for biosimilar candidate to Prolia, Xgeva Alvotech will develop and manufacture the product, and Dr. Reddy’s will register and commercialize it in the applicable markets. Teva, Alvotech intro Humira biosimilar Simlandi is the first interchangeable high-concentration, citrate-free biosimilar to Humira. Avenacy intros generic Isuprel Isoproterenol hydrochloride injection had a market value of approximately $26 million for the 12 months ending in June 2023, per IQVIA. FDA approves Elite’s generic Methotrexate Methotrexate belongs to a class of drugs known as antimetabolites. Hikma enters Spanish generic injectables market In the year to date, Hikma has received 36 product approvals and launched 25 products in Spain. Upsher-Smith named 2024 ASAP Alliance Excellence Award finalist Upsher-Smith was recognized in both the Individual Long-Standing Alliance and Individual Company Alliance Excellence award categories. Glenmark obtains FDA OK for generic Combigan Generic Combigan is used for the reduction of intraocular pressure in patients with glaucoma who require additional IOP-lowering therapy. Camber debuts generic Banzel Rufinamide Oral Suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients aged 1 year old and older, and in adults. Hims & Hers Health offers GLP-1 injections Hims & Hers has formed a partnership with a U.S. manufacturer of generic and 503B compounded injectable medications for lower cost GLP-1 injections. First Previous 32 33 34 35 36 Next Last
